Pharmaceutical - Mallinckrodt


Current filters:


Popular Filters

Horizon Pharma buys US rights to Nuvo’s Pennsaid for $45 million


Canadian specialty drugmaker Nuvo Research says it has completed the sale of its osteoarthritis pain…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingMallinckrodtNuvo ResearchPennsaidPharmaceuticalUSA

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial

Mallinckrodt’s MNK-155 shows efficacy in Ph III acute pain trial


US drugmaker Mallinckrodt reported that a Phase III efficacy trial of investigational MNK-155 met the…


Mallinckrodt to acquire Questcor Pharma for around $5.6 billion

Mallinckrodt to acquire Questcor Pharma for around $5.6 billion


In a second M&A deal so far this year, Ireland-headquartered Mallinckrodt says it has entered a definitive…

ActharBusinessBusiness FinanceCorporate financeMallinckrodtMergers & AcquisitionsPharmaceuticalPharmaceuticalsQuestcor PharmaStock market

Mallinckrodt gains FDA approval for Xartemis XR

Mallinckrodt gains FDA approval for Xartemis XR


The US Food and Drug Administration has approved Ireland-headquartered specially drugmaker Mallinckrodt’s…

DepomedMallinckrodtNeurologicalNorth AmericaPharmaceuticalRegulationUSAXartemis XR

Mallinckrodt to buy Cadence Pharma for around $1.3 billion


Ireland-headquartered specialty drugmaker Mallinckrodt, spun off by Covidien last year, has entered into…

Cadence PharmaceuticalsMallinckrodtMergers & AcquisitionsOfirmevPharmaceutical

US FDA accepts Pennsaid 2% NDA for review


The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Nuvo Research files law suit against Mallinckrodt


Canadian specialty pharma company Nuvo Research (TSX: NRI) says it has commenced legal action against…

Anti-Arthritics/RheumaticsLegalLicensingMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceutical

US FDA grants priority review for Mallinckrodt's pain relief drug


The US Food and Drug Administration has accepted and granted a priority review for the New Drug Application…

DepomedMallinckrodtNorth AmericaOxycodone and AcetaminophenPharmaceuticalRegulation

Nuvo's partner Mallinckrodt to resubmit osteoarthritis treatment to US FDA


Canada's Nuvo Research (TSX: NRI) says that its licensing partner Mallinckrodt (NYSE: MNK) has successfully…

Anti-Arthritics/RheumaticsCovidienMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Covidien to spin out pharma business to Mallinckrodt


Ireland-based health care products group Covidien (NYSE: COV) says that its board of directors has approved…

CovidienMallinckrodtMergers & AcquisitionsPharmaceutical

Mallinckrodt Medical to distribute Rapiscan in France, Italy, Belgium, and Spain


Rapidscan Pharma Solutions (RPS) EU has entered into an agreement with Mallinckrodt Medical BV for the…

Cardio-vascularEuropeLicensingMallinckrodtMarkets & MarketingPharmaceuticalRapidscan Pharma SolutionsRapiscan

Covidien files Form 10 registration statement for planned spin-off of Pharma business


Ireland-based medical products and generic drugmaker Covidien (NYSE: COV) has announced the initial filing…

CovidienMallinckrodtMergers & AcquisitionsPharmaceutical

Mallinckrodt to acquire CNS Thera for $100 million; Mediq to sell out for 775 million euros


Mallinckrodt, the soon to be spun-out pharmaceuticals business of Ireland-based Covidien (NYSE: COV),…

CNS TherapeuticsCovidienGenericsMallinckrodtMediqMergers & AcquisitionsPharmaceutical

Back to top